Spero Theraoeutics deal with Innovent Biologics

Spero spending GSK milestone money to purchase asset from Innovent Biologics? A deal with Innovent Biologics to license rights to a new asset to enter a Phaze 2 FDA trial in US? Fierce Pharma had an article this morning detailing a deal being worked on.

[https://www.fiercebiotech.com/biotech/spero-shifts-focus-ii-11b-biobucks-antibody-licensing-deal-innovent-and-105m-raise](https://www.fiercebiotech.com/biotech/spero-shifts-focus-ii-11b-biobucks-antibody-licensing-deal-innovent-and-105m-raise)